Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2507.10269 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866913940029571072 |
|---|---|
| author | Maleyeff, Lara Leclair, Valérie Golchi, Shirin Hudson, Marie |
| author_facet | Maleyeff, Lara Leclair, Valérie Golchi, Shirin Hudson, Marie |
| contents | Pilot feasibility studies play a pivotal role in the development of clinical trials for rare diseases, where small populations and slow recruitment often threaten trial viability. While such studies are commonly used to assess operational parameters, they also offer a valuable opportunity to inform the design and analysis of subsequent definitive trials-particularly through the use of Bayesian methods. In this paper, we demonstrate how data from a single, protocol-aligned pilot study can be incorporated into a definitive trial using robust meta-analytic-predictive priors. We focus on the case of a binary efficacy outcome, motivated by a feasibility trial of intravenous immunoglobulin tapering in autoimmune inflammatory myopathies. Through simulation studies, we evaluate the operating characteristics of trials informed by pilot data, including sample size, expected trial duration, and the probability of meeting recruitment targets. Our findings highlight the operational and ethical advantages of leveraging pilot data via robust Bayesian priors, and offer practical guidance for their application in rare disease settings. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2507_10269 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods Maleyeff, Lara Leclair, Valérie Golchi, Shirin Hudson, Marie Applications Pilot feasibility studies play a pivotal role in the development of clinical trials for rare diseases, where small populations and slow recruitment often threaten trial viability. While such studies are commonly used to assess operational parameters, they also offer a valuable opportunity to inform the design and analysis of subsequent definitive trials-particularly through the use of Bayesian methods. In this paper, we demonstrate how data from a single, protocol-aligned pilot study can be incorporated into a definitive trial using robust meta-analytic-predictive priors. We focus on the case of a binary efficacy outcome, motivated by a feasibility trial of intravenous immunoglobulin tapering in autoimmune inflammatory myopathies. Through simulation studies, we evaluate the operating characteristics of trials informed by pilot data, including sample size, expected trial duration, and the probability of meeting recruitment targets. Our findings highlight the operational and ethical advantages of leveraging pilot data via robust Bayesian priors, and offer practical guidance for their application in rare disease settings. |
| title | The efficiencies of pilot feasibility trials in rare diseases using Bayesian methods |
| topic | Applications |
| url | https://arxiv.org/abs/2507.10269 |